Answers are grounded in this paper and cite their sources.
Despite a nominal amelioration for flow-dependent dilatation, significant effects of short-term treatment with alirocumab on vascular function were not detectable. More work would be needed to evaluate, whether fractional anisotropy may be useful in clinical atherosclerosis research.
No takes yet. Share an insight, caveat, or question.
Metzner et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: